Dasatinib Anhydrous
Dasatinib Anhydrous is a targeted therapy medication known as a tyrosine kinase inhibitor (TKI) that works by blocking specific proteins involved in cancer cell growth and division. It is primarily used to treat certain types of leukemia, including chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) in patients who have developed resistance or intolerance to other treatments.
A targeted cancer therapy that inhibits tyrosine kinases to treat certain leukemias in patients resistant to other treatments.
Key facts at a glance
- RxNorm
- 1546019
- Generic
- Dasatinib Anhydrous
- Class
- pin-variant
- Brands
- —
- Availability
- rx
- Lactation
- unknown
- Routes
- —
- Forms
- —
- Regions
- US, EU, CN, JP
- Monitoring
- —
This page is for informational purposes only.
Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.
Dasatinib is used to treat adults with newly diagnosed chronic phase chronic myeloid leukemia (CML), as well as adults and children with CML or Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) that has become resistant or intolerant to prior therapy including imatinib.
Dasatinib is a multi-targeted tyrosine kinase inhibitor that blocks the activity of the BCR-ABL kinase (produced by the Philadelphia chromosome abnormality) as well as SRC family kinases. By inhibiting these cancer-promoting proteins, it interferes with abnormal cell signaling that drives uncontrolled growth of cancer cells.
Common side effects may include fluid retention, diarrhea, headache, skin rash, and myelosuppression (low blood cell counts). Patients should be monitored for signs of bleeding, fluid retention, and cardiac function. Dasatinib may cause fetal harm and should not be used during pregnancy. Drug interactions are possible with medications that affect stomach acid or CYP3A4 metabolism.
Official drug label
WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy